Browsing by Yonsei Author : Park, Jeong Youp

eperson profile image
Name:
Park, Jeong Youp [박정엽]
orcid http://orcid.org/0000-0003-0110-8606
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (9247336900)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 143

This table browses all dspace content
Issue DateTitleJournal Title
2023Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study FRONTIERS IN ONCOLOGY
2023FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review ANNALS OF SURGICAL ONCOLOGY
2023Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study SCIENTIFIC REPORTS
2023Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort StudyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2023The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer GUT AND LIVER
2023Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis ADVANCED SCIENCE
2023Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trialGASTROINTESTINAL ENDOSCOPY
2023Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care YONSEI MEDICAL JOURNAL
2022A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma INTERNATIONAL JOURNAL OF CANCER
2022Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer CANCERS
2022Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer CANCERS
2022Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial CANCERS
2022Insulin-Like Growth Factor-1 Receptor Targeted Fluorescent Imaging for Gallbladder Cancer in Orthotopic Mouse Models GUT AND LIVER
2022EGFR-targeted fluorescent imaging using the da Vinci® Firefly™ camera for gallbladder cancer WORLD JOURNAL OF SURGICAL ONCOLOGY
2022Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study CANCERS
2022Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis GUT AND LIVER
2022BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients CANCERS
2021Optimal drainage of anastomosis stricture after living donor liver transplantationSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2021Expert consensus on endoscopic papillectomy using a Delphi process GASTROINTESTINAL ENDOSCOPY
2021Usefulness of Smartphone Apps for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial JMIR MHEALTH AND UHEALTH
2021Complete response of locally advanced left-sided pancreatic cancer after modified FOLFIRINOX chemotherapy followed by conversion surgery: A case report Annals of Hepato-biliary-pancreatic Surgery
2021Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis SCIENTIFIC REPORTS
2021Laparoscopic pancreaticoduodenectomy with excision of aberrant right hepatic artery after preoperative segmental embolization in mid-bile duct cancer Journal of Minimally Invasive Surgery
2021Pancreaticoduodenectomy with combined hepatic artery and portal vein resection after laparoscopic division of pancreaticosplenic ligament due to FOLFIRINOX-induced hepatic toxicity related secondary hypersplenism Annals of Hepato-biliary-pancreatic Surgery
2021Comparison of high flow nasal oxygen and conventional nasal cannula during gastrointestinal endoscopic sedation in the prone position: a randomized trialCANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE
2021Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancerEBIOMEDICINE
2021Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean populationACTA RADIOLOGICA
2021Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIALSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2020Neoadjuvant chemotherapy followed by total pancreatectomy with splenectomy and combined vascular resections after preoperative percutaneous transhepatic portal vein stent placement in locally advanced pancreatic cancer with portal vein total obliteration Annals of Hepato-biliary-pancreatic Surgery
2020Lewis Antigen Phenotype and Survival of Patients With Pancreatic CancerPANCREAS
2020Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?PANCREATOLOGY
2020Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2020FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
2020Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer GUT AND LIVER
2019Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal AdenocarcinomaPANCREAS
2019소화기암 치료 후 발생하는 2차 원발성 암 Korean Journal of Gastroenterology
2019Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX ChemotherapyNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2019A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study PLoS One
2019Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture CANCER MEDICINE
2019Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis YONSEI MEDICAL JOURNAL
2019KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective studyHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
2018Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses CLINICAL ENDOSCOPY
2018Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
2018Oncologic outcomes after radical surgery for periampullary cancer in octogenarians Annals of Hepato-biliary-pancreatic Surgery
2018Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer SCIENTIFIC REPORTS
2018Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis PLOS ONE
2017Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort studySEMINARS IN ONCOLOGY
2017Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract CancerCHEMOTHERAPY

Browse

Links